Idorsia announces a cost reduction initiative to be implemented by the end of 2023
Ad hoc announcement pursuant to Art. 53 LR In order to give Idorsia the necessary time to realize commercial success...
Pharmaceutical
Emergent BioSolutions Receives U.S. FDA Approval of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
Emergent has been delivering CYFENDUS™ vaccine to the U.S. Department of Health and Human Services since 2019, under pre-Emergency Use...
Cidara Therapeutics Provides Update on Status of Ongoing CD388 Influenza Program
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed...
Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New Hires
WESTLAKE VILLAGE, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced...
Travere Therapeutics to Report Second Quarter 2023 Financial Results
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report second quarter...
Cosmos Health Inc. Announces Pricing of $5.25 Million Registered Direct Offering and Concurrent Private Placement
CHICAGO, IL / ACCESSWIRE / July 20, 2023 / Cosmos Health Inc. (the "Company") (NASDAQ:COSM), a global healthcare group with...
Chiesi USA CEO Appointed to ASHP Foundation Board of Directors
CEO Jon Zwinski to serve a two-year term on the Board of Directors starting in June 2023, deepening the partnership...
Artelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023
New data demonstrates that ART26.12 works by activating multiple receptors implicated in pain signaling and is able to broadly modify...
Abeona Therapeutics Joins Rare Disease Company Coalition
CLEVELAND, July 19, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it has joined the Rare...
Zymeworks To Host Second Quarter 2023 Results Conference Call
VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional...
Journey Medical Corporation to Announce Second Quarter 2023 Financial Results the Week of August 7, 2023
Company to host conference call to discuss financial results and provide a corporate update the week of August 7, 2023SCOTTSDALE,...
Inozyme Pharma to Provide ENPP1 Deficiency Program Update on July 26, 2023
– Conference call and webcast to be held on July 26, 2023, at 8am ET – BOSTON, July 19, 2023...
Tenax Therapeutics Issued U.S. Patent for Oral Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
New U.S. patent provides intellectual property (IP) protection until December 2040, and may qualify for term extension beyond 2040There are...
First Wave BioPharma, Inc. Announces Pricing of $2.1 Million Public Offering
BOCA RATON, Fla., July 19, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”),...
Akari Therapeutics Appoints Experienced Life Sciences Executive Wendy DiCicco as Interim Chief Financial Officer
NEW YORK and LONDON, July 19, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing...
Oculis to Present at OIS Retina Innovation Summit
ZUG, Switzerland, and BOSTON, July 19, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company...
Rhythm Pharmaceuticals Announces Two Publications Detailing Burden of Hyperphagia and Obesity on Patients and Caregivers Living with Bardet-Biedl Syndrome
Results of The CAREgiver Burden in BBS (CARE-BBS) study show multifaceted burden of hyperphagiaBOSTON, July 19, 2023 (GLOBE NEWSWIRE) --...
Hydreight Provides Corporate Update Citing Tremendous Growth Along With New Features And Services
VANCOUVER, British Columbia and LAS VEGAS, July 19, 2023 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV:...
Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE(R) in the U.S. with Pentec Health
Recent Pentech Health acquisition of ZOIA Pharma broadens distribution and access for patients to PKU GOLIKE®GENEVA, SWITZERLAND / ACCESSWIRE /...
Protagonist Therapeutics Reports Granting of Inducement Award
NEWARK, CA / ACCESSWIRE / July 18, 2023 / Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on July 17, 2023,...